国产999免费视频|亚洲欧美激情综合首页|动漫人妻h无码中文字幕|国产精品欧美日韩视频一区|美女精品人妻视频一区二区|中文亲近交尾bd在线播放|色五月丁香亚洲高清无码国产|久久一区国产男人操女人的视频

position: EnglishChannel  > Policy> China's R&D Investment Hit 3 Trln RMB in 2022

China's R&D Investment Hit 3 Trln RMB in 2022

Source: Science and Technology Daily | 2023-09-25 15:30:24 | Author: By CHEN Chunyou & LIU Yin

A researcher observes the growth of active algal cells at a laboratory of a biotech company in Dezhou city, Shandong province. (PHOTO: VCG)

By CHEN Chunyou & LIU Yin

China invested over 3 trillion RMB in research and development (R&D) in 2022, a year-on-year increase of 282 billion RMB, according to a communique on national science and technology expenditures last year released by the National Bureau of Statistics (NBS), Ministry of Science and Technology and Ministry of Finance on September 18.

New record for basic research funding

The total funding for basic research exceeded 200 billion RMB for the first time, accounting for 6.57 percent of R&D funding.

The proportion of basic research expenditure in R&D expenditure increased by 0.07 percentage point over the previous year, remaining above 6 percent for four consecutive years. The proportion of applied research expenditure also increased, reaching 11.3 percent.

China has implemented various measures to encourage corporate and social funds to support basic research for consolidating sci-tech innovation and enhancing original innovation, Xuan Zhaohui, a researcher from the Chinese Academy of Science and Technology for Development, told Science and Technology Daily. These measures include establishing joint funds and promoting social donations.

Xuan called the increase in basic research expenditure the result of improved awareness of original innovation across society and favorable measures, which have enhanced China's original innovation ability and facilitated high-quality socioeconomic development.

Enterprises contribute to R&D expenditure growth

In 2022, the R&D expenditure of enterprises was 2,387.86 billion RMB, signifying an 84-percent contribution to the growth of R&D funds, 4.6 percentage points higher than in 2021. Government-affiliated research institutions' expenditure was 381.44 billion RMB while universities spent 241.24 billion RMB.

"In recent years, enterprises have been prioritized in applications for science and technology plan projects. They also benefited from pre-tax deductions on R&D expenses and gaining access to scientific equipment because of the sharing mechanism," Xuan said.

The researcher added that these factors have motivated enterprises to engage in R&D activities, contributing to the increase in R&D investment.

The R&D expenditure of enterprises accounted for 77.6 percent of the total gross domestic R&D expenditure in 2022, a proportion close to those in Japan, the Republic of Korea and the U.S.

China's high-tech manufacturing is a pillar of industrial transformation and upgrading. Not surprisingly, R&D investment in this sector crossed 600 billion RMB in 2022, an increase of 14.5 percent over the previous year.?

Zhang Qilong, an NBS official, said the increased R&D intensity in key fields has created conducive conditions for core technology research and improvement of industrial capabilities.

According to the communique, the number of provinces and municipalities with R&D funding exceeding 100 billion RMB has increased to 12. In terms of regional distribution of R&D expenditure, Beijing, Shanghai and the Guangdong-Hong Kong-Macao Greater Bay Area, as well as the Yangtze River Delta region have played a crucial role in spearheading the advancements.

Zhang said there should be targeted support for key technology fields while investment in the commercialization of research results should be increased to improve funding efficiency.

Editor:陳春有

Top News

Jointly Protecting People's Rights in Digital Era

?Emerging technologies like AI, big data and the Internet of Things are rapidly reshaping the world in this era of digital intelligence. However, they are also bringing challenges to human rights, which makes joint efforts essential. Science and Technology Daily spoke with international experts on these issues against the backdrop of the 2025 China-Europe Seminar on Human Rights hosted by the China Society for Human Rights Studies and Cátedra China Foundation in Madrid, Spain, on June 25 on the theme "Human Rights in the Era of Digital Intelligence."

First Human Clinical Trial of Invasive BCI in China

A major breakthrough in neurotechnology has been achieved with the successful completion of China's first-in-human clinical trial of an invasive brain-computer interface (BCI) system. With that China becomes the second country in the world to reach the clinical stage in this field.

抱歉,您使用的瀏覽器版本過低或開啟了瀏覽器兼容模式,這會(huì)影響您正常瀏覽本網(wǎng)頁

您可以進(jìn)行以下操作:

1.將瀏覽器切換回極速模式

2.點(diǎn)擊下面圖標(biāo)升級(jí)或更換您的瀏覽器

3.暫不升級(jí),繼續(xù)瀏覽

繼續(xù)瀏覽
鄂尔多斯市| 文山县| 广东省| 搜索| 平南县| 寻乌县| 云南省| 印江| 万安县| 烟台市| 澄城县| 贞丰县| 南昌市| 六盘水市| 桦南县| 建阳市| 涞水县| 盐山县| 绥德县| 罗甸县| 闽清县| 玛多县| 河北区| 白河县| 呼玛县| 芷江| 宁城县| 尉氏县| 文山县| 思南县| 双牌县| 黄龙县| 武鸣县| 城步| 星子县| 儋州市| 大关县| 平舆县| 名山县| 望都县| 阳谷县|